Literature DB >> 25548379

Five cases of recurrent meningitis associated with chronic strongyloidiasis.

Teppei Shimasaki1, Heath Chung2, Soichi Shiiki2.   

Abstract

Although meningitis secondary to chronic strongyloidiasis is a rare complication, it is associated with a high mortality rate. Recurrent meningitis can occur if the underlying parasitic infection is left untreated. We report five cases of recurrent meningitis related to chronic strongyloidiasis that were associated with human T-lymphotropic virus type 1 (HTLV-1) infection. Common causative organisms are Escherichia coli, Streptococcus bovis, and Klebsiella pneumonia. One patient died during the second episode of meningitis. Three patients showed significant gastrointestinal and respiratory symptoms before developing headache and fever. In four cases, patients developed multiple recurrences even with the treatment of thiabendazol. Ivermectin seems to be a better agent compared with thiabendazol to achieve eradication of strongyloidiasis. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25548379      PMCID: PMC4350558          DOI: 10.4269/ajtmh.14-0564

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

1.  Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful?

Authors:  Beverley-Ann Biggs; Sonia Caruana; Seema Mihrshahi; Damien Jolley; Jenne Leydon; Ley Chea; Sophy Nuon
Journal:  Am J Trop Med Hyg       Date:  2009-05       Impact factor: 2.345

2.  Fatal recurrent bacterial meningitis: a complication of chronic Strongyloides infection.

Authors:  Marina Somin; Vladimir Neogolani; Oren Zimhony; Alex Wolpart; Nadia Sokolowski; Stephen Malnick
Journal:  Eur J Intern Med       Date:  2008-04-18       Impact factor: 4.487

3.  Faecal examination and PCR to detect Strongyloides venezuelensis in experimentally infected Lewis rats.

Authors:  Nelson Mendes Marra; Fernanda Chiuso-Minicucci; Gabriel Capella Machado; Sofia Fernanda Gonçalves Zorzella-Pezavento; Thaís Graziela Donegá França; Larissa Lumi Watanabe Ishikawa; Alessandro F T Amarante; Alexandrina Sartori; Mônica R V Amarante
Journal:  Mem Inst Oswaldo Cruz       Date:  2010-02       Impact factor: 2.743

Review 4.  Diagnosis of Strongyloides stercoralis infection.

Authors:  A A Siddiqui; S L Berk
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

Review 5.  Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis.

Authors:  K Link; R Orenstein
Journal:  South Med J       Date:  1999-07       Impact factor: 0.954

6.  Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.

Authors:  M Satoh; H Toma; Y Sato; M Takara; Y Shiroma; S Kiyuna; K Hirayama
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

Review 7.  Strongyloides stercoralis in the Immunocompromised Population.

Authors:  Paul B Keiser; Thomas B Nutman
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

8.  Community-acquired recurrent bacterial meningitis in adults.

Authors:  Kirsten S Adriani; Diederik van de Beek; Matthijs C Brouwer; Lodewijk Spanjaard; Jan de Gans
Journal:  Clin Infect Dis       Date:  2007-07-23       Impact factor: 9.079

9.  Intestinal strongyloidiasis and hyperinfection syndrome.

Authors:  Raja S Vadlamudi; David S Chi; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2006-05-30

10.  Meningitis associated with strongyloidiasis in an area endemic for strongyloidiasis and human T-lymphotropic virus-1: a single-center experience in Japan between 1990 and 2010.

Authors:  Y Sasaki; T Taniguchi; M Kinjo; R L McGill; A T McGill; S Tsuha; S Shiiki
Journal:  Infection       Date:  2013-06-13       Impact factor: 3.553

View more
  4 in total

1.  A Case of Bacteremia and Meningitis Associated with Piperacillin-Tazobactam Nonsusceptible, Ceftriaxone Susceptible Escherichia coli during Strongyloides Hyperinfection in an Immunocompromised Host.

Authors:  Santosh Dahal; Jeffrey Lederman; Jesse Berman; Marius Viseroi; Stephen Jesmajian
Journal:  Case Rep Infect Dis       Date:  2017-11-22

Review 2.  The Unique Life Cycle of Strongyloides stercoralis and Implications for Public Health Action.

Authors:  Wendy Page; Jenni A Judd; Richard S Bradbury
Journal:  Trop Med Infect Dis       Date:  2018-05-25

Review 3.  Anemia, intractable vomiting, chronic diarrhea, and syndrome of inappropriate antidiuretic secretion: a diagnostic dilemma: Disseminated strongyloidosis in a patient with newly diagnosed HTLV infection-case report and review of literature.

Authors:  Hassan Tariq; Muhammad Umar Kamal; Pavithra Reddy; Bharat Bajantri; Masooma Niazi; Ajsza Matela; Cosmina Zeana; Ariyo Ihimoyan; Anil Dev; Sridhar Chilimuri
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

4.  Clinical Characteristics of Disseminated Strongyloidiasis, Japan, 1975-2017.

Authors:  Mitsuru Mukaigawara; Masashi Narita; Soichi Shiiki; Yoshihiro Takayama; Shunichi Takakura; Tomokazu Kishaba
Journal:  Emerg Infect Dis       Date:  2020-03       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.